US Patent Issued to VANDERBILT UNIVERSITY on Sept. 9 for "Human monoclonal antibodies to enterovirus D68" (Tennessee Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,241, issued on Sept. 9, was assigned to VANDERBILT UNIVERSITY (Nashville, Tenn.).

"Human monoclonal antibodies to enterovirus D68" was invented by James E. Crowe Jr. (Nashville, Tenn.) and Matthew R. Vogt (Nashville, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to human and engineered antibodies and fragments thereof binding to enterovirus D68 (EV-D68), engineered cells producing the same, and of using the antibodies and fragments thereof in methods for both diagnosing and treating EV-D68 infections. Also disclosed are vaccine formulations comprising one of more of the antibody and fragments thereof, as we...